The user facility reported to terumo cardiovascular that at the end cardiopulmonary bypass, a clot was noticed on the walls of the venous reservoir, when filling the patient with volume.The patient was still at 19 degrees when the reservoir was clamped and changed out.There was a delay of less than one minute for change out.The act was 569 just prior to cpb and that few thousand more of heparin was given before full cpb.There was no blood loss since the extra volume that was given was able to be hemoconcentrated prior to change out.No known impact or consequence to patient.Product was changed out.Procedure was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on july 11, 2018.(b)(4).The actual sample was not returned for evaluation; therefore a definitive root cause could not be determined.A retention sample from the same product code and lot number combination was performance tested no anomalies found.Visual inspection was also conducted prior to the test, and no anomalies were noted.The root cause could not be determined in the investigation.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|